Increased Circulating Plasma Cells Detected by Flow Cytometry Predicts Poor Prognosis in Patients With Plasma Cell Myeloma

Cytometry Part B - Clinical Cytometry - United States
doi 10.1002/cyto.b.21606
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Increased Plasma Prothrombin Time Is Associated With Poor Prognosis in Patients With Paraquat Poisoning

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

PLoS ONE
Multidisciplinary
2011English

Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Should We Be Routinely Testing for Circulating Clonal Plasma Cells in Patients With Multiple Myeloma?

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2018English

Plasma Cell Satellitism in Plasma Cell Myeloma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients

Oncotarget
Oncology
2017English

Determination of Circulating Tumor Cells by Flow Cytometry in the Bladder Cancer Patients

Urology and Andrology – Open Journal
2018English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

Post-Treatment Plasma EBV-DNA Positivity Predicts Early Relapse and Poor Prognosis for Patients With Extranodal NK/T Cell Lymphoma in the Era of Asparaginase

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy